RCC2 is a novel p53 target in suppressing metastasis

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• RCC2 (TD60) is a conserved protein linked to colorectal cancer prognosis.
• Its role in tumor development and progression requires further elucidation.

Purpose of the Study:

• To define the signaling pathway regulating RCC2 and its function in tumor progression.
• To investigate the relationship between p53, RCC2, and Rac1 in colorectal cancer.

Main Methods:

• Identified p53 as a transcriptional regulator of RCC2 via promoter binding.
• Determined RCC2's physical interaction and deactivation of Rac1 using crystal structure analysis.
• Assessed cell migration and haptotaxis in p53/RCC2 deficient and wild-type cells.

Main Results:

• p53 binds to the RCC2 promoter, regulating its transcription.
• RCC2 deactivates the pro-metastatic GTPase Rac1 via physical interaction.
• p53 or RCC2 deficiency activates Rac1, impairing directional cell migration and extracellular matrix sensing.
• Ectopic RCC2 expression rescues migration defects in p53-null cells.

Conclusions:

• The p53/RCC2/Rac1 axis is critical for regulating cell migration and suppressing metastasis in colorectal cancer.
• This signaling pathway represents a potential therapeutic target for colorectal cancer treatment.